Biomarkers of Response to Camrelizumab Combined with Apatinib: an Analysis from a Phase II Trial in Recurrent/metastatic Nasopharyngeal Carcinoma.
British journal of cancer（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined